Avenir Corporation’s AbbVie ABBV Stock Holding History

Avenir Corporation’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$368K	Hold	1,462	–	–	0.04%	61
2026 Q1	$318K	Hold	1,462	–	–	0.04%	58
2025 Q4	$334K	Hold	1,462	–	–	0.04%	60
2025 Q3	$339K	Hold	1,462	–	–	0.04%	59
2025 Q2	$271K	Hold	1,462	–	–	0.03%	65
2025 Q1	$306K	Hold	1,462	–	–	0.03%	57
2024 Q4	$260K	Hold	1,462	–	–	0.03%	60
2024 Q3	$289K	Hold	1,462	–	–	0.03%	58
2024 Q2	$251K	Hold	1,462	–	–	0.02%	62
2024 Q1	$266K	Hold	1,462	–	–	0.02%	61
2023 Q4	$227K	Hold	1,462	–	–	0.02%	60
2023 Q3	$218K	Buy	+1,462	New	+$215K	0.02%	57
2023 Q2	–	Sell	-1,462	Closed	-$233K	–	61
2023 Q1	$233K	Hold	1,462	–	–	0.02%	59
2022 Q4	$236K	Buy	+1,462	New	+$224K	0.02%	58
2022 Q3	–	Sell	-1,462	Closed	-$224K	–	61
2022 Q2	$224K	Hold	1,462	–	–	0.02%	58
2022 Q1	$237K	Buy	+1,462	New	+$212K	0.02%	61

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Avenir Corporation's ABBV Position: Q2 2026 in Review

Avenir Corporation held its AbbVie (ABBV) position steady in Q2 2026 at 1,462 shares worth $368K. The position accounts for 0.04% of the portfolio, ranked #61.

Avenir Corporation first reported a position in ABBV in Q1 2022 and has held it in 16 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Avenir Corporation held 1,462 shares of AbbVie worth $368K as of Q2 2026.
Avenir Corporation left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.04% of Avenir Corporation's portfolio in Q2 2026, its #61 holding.
Avenir Corporation first reported a position in AbbVie in Q1 2022 and has held it in 16 quarters since.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Avenir Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.